7 completed. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 7 |
| Phase 2 | 2 | Completed 2 |
Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EBRT + Lu-PSMA for N1M0 Prostate Cancer 177Lu-PSMA-617, EBRT - Prostatic Neoplasm | Phase 1 | Completed | The Netherlands Cancer Institute | 14 | 2021-12-20 | 2025-12-10 |
| Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit Gallium-68 PSMA-11 prepared using PSMA-11 Sterile Cold Kit - Prostatic Neoplasm | Phase 1 | Completed | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 3 | 2019-01-24 | 2020-10-26 |
| Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy 18F-DCFPyL, Tumor Irradiation, Prostate + tumor irradiation - Prostate Cancer, Prostatic Neoplasm | Phase 1 | Completed | National Cancer Institute (NCI) | 17 | 2018-07-05 | 2025-10-08 |
| Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer radioimmuniguided intenstiy modulated radiotherapy - Prostatic Neoplasm | Phase 1 / Phase 2 | Completed | Mayo Clinic | 72 | 2006-10-01 | 2011-02-25 |
| Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms PF00562271 - Head and Neck Neoplasm, Prostatic Neoplasm | Phase 1 | Completed | Verastem, Inc. | 99 | 2005-12-01 | 2013-03-21 |
| Preop Conformal Radiotherapy - Prostate Pre-Operative Conformal Radiotherapy - Prostatic Neoplasm | Phase 1 / Phase 2 | Completed | University Health Network, Toronto | 15 | 2000-05-01 | 2010-08-11 |
| A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms 7-hydroxystaurosporine (UCN-01) - Breast Cancer, Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 51 | 1995-08-01 | 2008-03-04 |
Prostatic Neoplasms (7) · Breast Neoplasms (1) · Head and Neck Neoplasms (1) · Lymphoma (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Genital Diseases (7) · Genital Diseases, Male (7) · Genital Neoplasms, Male (7) · Male Urogenital Diseases (7) · Neoplasms by Site (7) · Prostatic Diseases (7) · Urogenital Diseases (7) · Urogenital Neoplasms (7) · Neoplasms (6) · Breast Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Hemic and Lymphatic Diseases (1)
18F-JK-PSMA-7 (1) · 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1) · 7-hydroxystaurosporine (1) · PF-00562271 (1) · Pluvicto (1)
National Cancer Institute (NCI) (2) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Mayo Clinic (1) · The Netherlands Cancer Institute (1) · University Health Network, Toronto (1) · Verastem, Inc. (1)
United States (4) · Canada (2) · Australia (1) · Belgium (1) · Netherlands (1)
Deborah E Citrin, M.D. (1) · Padraig Warde, MD (1) · Wouter V Vogel, MD, PhD (1)